HypGen Inc. to Prese
HypGen Inc. to Present During Biotech Showcase 2018
January 05, 2018 09:45 ET | HypGen Inc.
CENTURY CITY, CA , Jan. 05, 2018 (GLOBE NEWSWIRE) -- HypGen Inc. (OTCQB: HPGN), announced it will present during the Biotech Showcase™ 2018, in San Francisco.  HypGen is developing the drug RP-323...
Eloxx.jpg
Eloxx Pharmaceuticals Chairman and CEO Robert Ward to Participate in a Panel Discussion at the Biotech Showcase 2018 Conference
January 04, 2018 11:39 ET | Eloxx Pharmaceuticals
WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (OTC:SVOND), a clinical-stage biopharmaceutical company developing novel small molecule medicines to treat...